Hyderabad:The US Food and Drug Administration has officially allowed Johns Hopkins University researchers to conduct clinical trials to test a therapy for COVID-19. The therapy will use plasma from recovering patients.
According to a release, this will allow the university to test the use of blood plasma to boost the immune systems of health-care providers, first responders and others who are at high risk of contracting the disease.
Arturo Casadevall, a Johns Hopkins infectious disease expert, believes that this could help in treating critically ill COVID-19 patients and will also be helpful in boosting the immune systems of health care providers.
This required a team of physicians and scientists from around the United States. After which a network of hospitals and blood banks were established that will collect, isolate, and process blood plasma from COVID-19 survivors.